Oncology CoPilot
The Oncology CoPilot Platform equips oncologists, diagnostic laboratories and research organizations with cutting-edge AI-powered drug-cancer biological network analysis software. It delves deep into the intricate tumor biology of every cancer patient, facilitating well-informed treatment decisions. By analyzing high-throughput gene expression profiling data, the platform conducts thorough evaluations of tumors, encompassing molecular subtyping, microenvironment, and immune response assessments. It then generates personalized therapy options, ranked by the probability of drug response. This empowers oncologists to craft precise and effective treatment plans tailored to each individual patient, across all cancer types, with access to over 240 drug options.
Clinician-Assistance Platform
Streamlining cancer treatment decisions by analyzing complex tumor gene expression data to identify the most effective drugs.
Treatment Decision Support
Generates a report with a ranked list of drug options by probability of success. Empowers clinicians to make informed and effective decisions.
Benefits & Outcomes
Reduce costs and save time from reviewing complex gene expression data. This leads to increased revenue and improved patient outcomes.
Our Approach
